Clinical trial
Magnetocardiography as an Innovative Diagnostic Tool for Early and Accurate Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
NCT06197724 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetocardiography as an Innovative Diagnostic Tool for Early and Accurate Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 2, 2024
- Completion date
- January 31, 2026
- Enrollment
- 14,090 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non st segment elevation acute coronary syndrome